Inverted Periosteal Flap vs Buccal Advancement Flap for Oroantral Communication Closure
Comparison of Inverted Periosteal Flap Versus Buccal Advancement Flap for Closure of Post-Extraction Maxillary Sinus Perforation: A Randomized Controlled Trial
研究概览
详细说明
Oroantral communication is an abnormal connection between the oral cavity and the maxillary sinus, most commonly occurring after extraction of maxillary posterior teeth. If not closed properly, it may lead to oroantral fistula or maxillary sinus complications.
This randomized controlled clinical study will compare the inverted buccal periosteal flap with the conventional buccal advancement flap for closure of recent post-extraction oroantral communications. The study will include 24 patients with communications measuring 3-6 mm and diagnosed within 48 hours after non-surgical extraction.
Participants will be randomly divided into two groups. In the test group, closure will be performed using the inverted buccal periosteal flap, where the periosteal layer is dissected, inverted over the defect, and sutured to the palatal tissue without tension. In the control group, closure will be performed using the buccal advancement flap, where a buccal mucoperiosteal flap is advanced palatally and sutured to cover the communication.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Damascus、叙利亚
- School of Dental Medicine
-
-
参与标准
资格标准
适合学习的年龄
- 成人
接受健康志愿者
描述
Inclusion Criteria:
- Presence of an oroantral communication (OAC) with a diameter between 3-7 mm.
- Communication resulting from extraction of posterior maxillary teeth (first molar, second molar, third molar, or second premolar).
- Recent perforation occurring no more than 48 hours prior to surgical intervention.
Exclusion Criteria:
- Presence of foreign bodies or residual tooth fragments within the maxillary sinus.
- Presence of systemic diseases that could impair wound healing (e.g., uncontrolled diabetes, immunosuppression).
- History of maxillary sinusitis prior to the perforation.
- Presence of periapical lesions or cysts at the extraction site.
- Smokers.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Inverted Buccal Periosteal Flap
Participants in this arm will receive surgical closure of the post-extraction oroantral communication using the inverted buccal periosteal flap.
A full-thickness mucoperiosteal flap will be elevated, the periosteal layer will be dissected and inverted over the defect, then sutured to the palatal tissue to achieve tension-free closure.
|
Surgical closure of post-extraction oroantral communication using an inverted buccal periosteal flap.
A full-thickness mucoperiosteal flap will be elevated, followed by dissection of the periosteal layer from the overlying mucosa.
The periosteal flap will then be inverted over the defect and sutured to the palatal tissue to achieve tension-free closure.
|
|
有源比较器:Buccal Advancement Flap
Participants in this arm will receive surgical closure of the post-extraction oroantral communication using the conventional buccal advancement flap.
A buccal mucoperiosteal flap will be elevated, advanced palatally, and sutured to the palatal mucosa to cover the communication.
|
Surgical closure of post-extraction oroantral communication using the conventional buccal advancement flap.
A buccal full-thickness mucoperiosteal flap will be elevated, released by periosteal scoring, advanced palatally, and sutured to the palatal mucosa to cover the communication.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Successful Closure of Oroantral Communication
大体时间:1 week, 15 days, and 45 days after surgery.
|
Successful closure will be assessed clinically by confirming the absence of oroantral fistula formation, absence of fluid leakage through the nose, and absence of air leakage or air bubbles during the Valsalva test.
|
1 week, 15 days, and 45 days after surgery.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Postoperative Pain
大体时间:Postoperative days 1, 3, 5, and 7.
|
Postoperative pain will be assessed using the Visual Analog Scale.
The scale ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst possible pain.
Higher scores indicate a worse outcome.
|
Postoperative days 1, 3, 5, and 7.
|
|
Postoperative Facial Edema
大体时间:Postoperative days 1, 3, and 5.
|
Facial edema will be assessed using extraoral linear measurements between fixed facial reference points.
The measured distances will be used to estimate postoperative facial swelling and compare changes between the two study groups.
Higher values indicate greater facial edema and therefore a worse outcome.
|
Postoperative days 1, 3, and 5.
|
合作者和调查者
调查人员
- 研究主任:Saleh Al Kurdi, PhD、Arab International University
- 首席研究员:Majd S Mohammad, DDs、Damascus University
- 学习椅:Omar A Heshmeh, PhD、Damascus University
出版物和有用的链接
一般刊物
- Visscher SH, van Minnen B, Bos RR. Closure of oroantral communications: a review of the literature. J Oral Maxillofac Surg. 2010 Jun;68(6):1384-91. doi: 10.1016/j.joms.2009.07.044. Epub 2010 Mar 12. No abstract available.
- Parvini P, Obreja K, Begic A, Schwarz F, Becker J, Sader R, Salti L. Decision-making in closure of oroantral communication and fistula. Int J Implant Dent. 2019 Apr 1;5(1):13. doi: 10.1186/s40729-019-0165-7.
- Lago-Mendez L, Diniz-Freitas M, Senra-Rivera C, Gude-Sampedro F, Gandara Rey JM, Garcia-Garcia A. Relationships between surgical difficulty and postoperative pain in lower third molar extractions. J Oral Maxillofac Surg. 2007 May;65(5):979-83. doi: 10.1016/j.joms.2006.06.281.
- Rosenfeld EA. Inverted periosteal flap: an alternative to the buccal advancement flap for tension-free, watertight closure. J Oral Maxillofac Surg. 2014 Jul;72(7):1244-50. doi: 10.1016/j.joms.2014.03.006. Epub 2014 Mar 20.
- Ibrahim MT, Gharieb EA, Sheta MS. A pedicled buccal periosteal flap for the closure of oro-antral fistula. BMC Oral Health. 2024 Apr 10;24(1):440. doi: 10.1186/s12903-024-04217-6.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- DN-230426-776
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.